Song ED, Xia HB, Zhang LX, Ma J, Luo PQ, Yang LZ, Xiang BH, Zhou BC, Chen L, Sheng H, Fang Y, Han WX, Wei ZJ, Xu AM. Efficacy and outcome of extensive intraoperative peritoneal lavage plus surgery vs surgery alone with advanced gastric cancer patients. World J Gastrointest Surg 2023; 15(3): 430-439 [PMID: 37032799 DOI: 10.4240/wjgs.v15.i3.430]
Corresponding Author of This Article
A-Man Xu, MD, Doctor, Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Ji-Xi Road, Hefei 230032, Anhui Province, China. xuaman@ahmu.edu.cn
Research Domain of This Article
Surgery
Article-Type of This Article
Clinical Trials Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Surg. Mar 27, 2023; 15(3): 430-439 Published online Mar 27, 2023. doi: 10.4240/wjgs.v15.i3.430
Table 1 The baseline characteristic analysis of the patients
Variables
Non-EIPL group, n = 75
EIPL group, n = 75
P value
Age in yr
66.93 ± 9.38
64.55 ± 8.22
0.099
Sex
0.200
Male
51
58
Female
24
17
BMI in kg/m2
21.51 ± 2.29
21.64 ± 3.34
0.786
Smoking status
0.373
Yes
55
50
No
20
25
Tumor location
0.260
Upper
21
14
Middle
11
17
Low
43
44
Differentiated grade
0.121
High
0
0
Middle
55
45
Low
20
30
T stage
0.405
T3
4
2
T4
71
73
N stage
0.112
N0
13
24
N1
18
12
N2
14
17
N3
30
22
Tumor size in cm
5.52 ± 2.21
5.37 ± 2.32
0.671
Borrmann classification
0.100
II
7
14
III
68
61
CEA in g/L
16.21 ± 78.06
14.13 ± 35.88
0.834
Neutrophil count as 109/L
3.49 ± 1.32
4.71 ± 8.39
0.215
Lymphocyte count as 109/L
1.35 ± 0.47
1.76 ± 2.48
0.164
NLR
3.02 ± 1.96
3.03 ± 2.20
0.989
Platelet as 109/L
202.52 ± 61.39
226.19 ± 90.94
0.064
Table 2 Outcomes after surgery
Variables
Non-EIPL group, n = 75
EIPL group, n = 75
P value
Type of surgery
0.242
Total
55
61
Distal
20
14
Time, surgery to first flatus in d
4.19 ± 0.99
3.95 ± 0.87
0.108
Postoperative hospital stay in d
15.26 ± 3.10
14.48 ± 1.97
0.072
Abdominal pain
10/75
5/75
0.174
Ileus
15/75
3/75
0.003
Abdominal abscess
9/75
1/75
0.009
Leakage
5/75
2/75
0.246
Bleeding
6/75
3/75
0.302
Neutrophil count as 109/L
10.36 ± 3.32
10.03 ± 3.56
0.552
Lymphocyte cell as 109/L
1.02 ± 0.63
1.00 ± 0.60
0.817
NLR
13.48 ± 8.55
11.87 ± 5.22
0.169
Platelet as 109/L
171.00 ± 59.98
179.73 ± 60.38
0.381
Table 3 Univariate analysis of overall survival
Variable
β
HR (95%CI)
P value
Sex
0.514
1.671 (0.983-2.841)
0.058
Age
0.024
1.025 (0.994-1.056)
0.114
EIPL/Non-EIPL
-0.991
0.371 (0.218,0.631)
0.000
Tumor size
0.192
1.211 (1.088-1.348)
0.000
Type of surgery
0.185
1.203 (0.653-2.214)
0.553
Tumor location
0.075
0.928 (0.689-1.250)
0.622
Borrmann classification
-1.474
0.229 (0.072-0.731)
0.013
Differentiated grade
0.491
0.612 (0.351-1.067)
0.083
T stage
1.250
3.489 (1.094-11.130)
0.035
N stage
0.535
1.707 (1.339-2.176)
0.000
Vascular invasion
-0.954
0.385 (0.235-0.632)
0.000
Table 4 Multivariate analysis of overall survival
Variable
β
HR (95%CI)
P value
EIPL/Non-EIPL
-0.861
0.423 (0.246-0.727)
0.002
Tumor size
0.139
1.149 (1.025-1.289)
0.017
Borrmann classification
-0.268
0.765 (0.211-2.775)
0.684
T stage
1.395
4.034 (1.255-12.971)
0.019
N stage
0.313
1.368 (1.034-1.811)
0.029
Vascular invasion
-0.608
0.545 (0.317-0.935)
0.027
Citation: Song ED, Xia HB, Zhang LX, Ma J, Luo PQ, Yang LZ, Xiang BH, Zhou BC, Chen L, Sheng H, Fang Y, Han WX, Wei ZJ, Xu AM. Efficacy and outcome of extensive intraoperative peritoneal lavage plus surgery vs surgery alone with advanced gastric cancer patients. World J Gastrointest Surg 2023; 15(3): 430-439